Admissions and credentials

Washington

District of Columbia

Experience

Group14 Technologies Closes $463 Million Series D and Acquisition of BAM Factory

August 20, 2025

Cooley advised Group14 Technologies, a global leader in advanced silicon battery materials, on the close of its $463 million Series D financing and acquisition of its joint venture with SK, Inc.

Read more

Related contacts

Alan Hambelton
Partner, Seattle
Phoebe Huang
Associate, Seattle
Millie Heuer
Associate, Seattle
Sharon Connaughton
Special Counsel, Washington, DC
Sarah Oliai
Associate, Washington, DC
Kevin King
Partner, Washington, DC
Lucy Bauer
Associate, Seattle
Christopher Kimball
Partner, Washington, DC
Sarah Sellers
Partner, New York
Brandon Lefebvre
Quantitative Analyst, Boston
Brian Woodard
Paralegal Specialist, Seattle
Nick Davis
Partner in Charge – Seattle, Seattle
Andrea Bromfeld
Special Counsel, New York
Andrew Epstein
Special Counsel, Seattle
Karen Tsai
Special Counsel, Washington, DC
Julie Wicklund
Special Counsel, Palo Alto
Alice C. Hu
Associate, San Francisco

Related Practices & Industries

Harvey Announces $300 Million Series E

June 24, 2025

Cooley advised Harvey, a domain-specific artificial intelligence platform for legal and professional services, on its $300 million Series E at a $5 billion valuation.

Read more

Related contacts

Matthew Bartus
Partner, San Francisco
Tara Capsuto
Partner, San Francisco
Christopher Kimball
Partner, Washington, DC
Xander Lee
Partner, Santa Monica
John Paul Oleksiuk
Partner, New York
John Sellers
Senior Counsel, Palo Alto
Sharon Connaughton
Special Counsel, Washington, DC
Rebecca Ross
Special Counsel, Washington, DC
Parker Armsby
Associate, New York
Kayla Blaker
Associate, Colorado
Dennis F. Craig II
Associate, Washington, DC
Millie Heuer
Associate, Seattle
Alice C. Hu
Associate, San Francisco
Carl Min
Associate, San Francisco
Tyler Saavedra-Buckley
Associate, San Francisco
Michael Suyat
Senior Paralegal, San Francisco
Katie Kissner
Quantitative Analyst, San Francisco
Brian Mitchell
Transactional Quantitative Analyst, San Diego

Related Practices & Industries

Archon Biosciences Announces $20 Million Seed Financing

October 30, 2024

Cooley advised Archon Biosciences, a biotechnology company pioneering computationally designed antibody cages (AbCs) to unlock powerful therapeutic targets beyond the reach of existing modalities, on its $20 million seed financing led by Madrona Ventures.

Read more

Related contacts

Colleen Badgley
Partner, Seattle
Alan W. Tamarelli
Partner, New York
Willy Cowles
Associate, Seattle
Lucy Bauer
Associate, Seattle
Brian Woodard
Paralegal Specialist, Seattle
John Sellers
Senior Counsel, Palo Alto
Timothy Shapiro
Partner, Palo Alto
Dr. Carol Laherty
Partner, Seattle
Millie Heuer
Associate, Seattle

Related Practices & Industries

Outpace Bio Announces $144 Million Oversubscribed Series B

August 1, 2024

Cooley advised Outpace Bio, a cell therapy company using unrivaled artificial intelligence-powered protein design to program immune cells for improved function inside patients battling solid tumors, on its $144 million oversubscribed Series B financing.

Read more

Related contacts

Colleen Badgley
Partner, Seattle
Sonya Erickson
Partner and Business Department Chair, Seattle
Christopher Kimball
Partner, Washington, DC
Mika Reiner Mayer
Partner, Palo Alto
John Sellers
Senior Counsel, Palo Alto
Timothy Shapiro
Partner, Palo Alto
Dillon Martinson
Special Counsel, Washington, DC
Rebecca Ross
Special Counsel, Washington, DC
Lucy Bauer
Associate, Seattle
Karen Gustavson
Associate, Seattle
Millie Heuer
Associate, Seattle
Brian Woodard
Paralegal Specialist, Seattle
Katie Kissner
Quantitative Analyst, San Francisco

Related Practices & Industries